Sorrento Therapeutics Inc.

As COVID re-emerges, Jim Cramer says it's time to look at companies that flourish in an economy that might get worse before it gets better.

Jim Cramer says small business is fueling our economy and investors should look to the companies supporting small business.

Corsair Gaming, Riot Blockchain, Torchlight Energy Resources, MicroStrategy and Sorrento Therapeutics are five top stock gainers for Monday.

Game plan for a heavy round of earnings next week.

Sorrento Therapeutics jumped after the biopharma said it applied for FDA emergency-use authorization for its covid-19 test.

The money will pay for development through Phase 2 clinical studies of a gene-encoded antibody, Sorrento said.

Even with new hopes for a vaccine, we'll still be fighting pandemic battles for a long time, says Jim Cramers. Here are some of the stocks investors should consider now.

Despite a stimulus stalemate and COVID-19 woes, the Europe-led selloff turned into a buying opportunity on Wall Street.

Sorrento's shares are up after the San Diego biopharma reported progress with the testing of its coronavirus treatments.

51Job, Herman Miller, Sorrento Therapeutics, Dr. Reddy Laboratories and U.S. Steel are among the top stock gainers for Thursday.

Sorrento is targeting a potential emergency use authorization submission as early as this year.

Jim Cramer explains the broad base for this rally -- a rally for both the COVID-19 stocks and the recovery stocks.

Stock futures are mostly higher, a day after the S&P 500 closes at a record high; Target, Lowe's and Nvidia report earnings; Democrats name Joe Biden as their presidential nominee.

It's not market manipulation, says Jim Cramer. He thinks it's clueless buying, and some investors will have no one to blame but themselves.

We're not winning the virus war, Jim Cramer says. So investors should look to the stocks that thrive in the COVID-19 stay-at-home economy.

Jim Cramer warns we're seeing binary action in the market, with investors betting impetuously, based on the latest news.

Sorrento Therapeutics says it has been cleared by the FDA for a Phase II trial of abivertinib, designed to fight covid.

Jim Cramer says during this time of COVID-19 contradiction, investors should identify which stocks stand out from the rest.

President Trump insinuated that a coronavirus vaccine is closer than many expect in remarks made Wednesday.

Here's why we're adding to this former bullpen name and closing out another.

We're selling large chunks of our holdings in Shift Technologies and Sorrento Therapeutics and plan to exit the latter name entirely.

Here we discuss news on three of our portfolio holdings -- most of it positive.

Yamana Gold, Southwestern Energy and AXT are set to report. Plus, news on 22nd Century and Sorrento Therapeutics.

Plus news on Sorrento Therapeutics and Wall Street weighs in on Southwestern Energy.

The portfolio added last week to AXT Inc., Sorrento Therapeutics and Cantaloupe and added SoFi Technologies to the bullpen.

We're losing a connection with this telecom but we're building on a defense play; also this drug developer moves to phase 3.

Let's check on this pharma name as well as BlackBerry and Antares.

Here's why we're pulling this drug-developer out of the bullpen and injecting it into the portfolio.

Here's why we're buying more Shift Technologies; also an update on Nokia and our bullpen name Sorrento Therapeutics.

Here's why Sorrento -- still a money loser -- is getting closer to becoming a holding.

As 2022 begins, it's out with the old and irrelevant stocks; also, let's take a hard look at retail.

Let's review the charts and indicators.

If there's a rally that doesn't move the needle for me.

I like to look for more compelling setups.

While those with a bearish bent often look for a 'sell the news' reaction to the Fed, that usually doesn't happen, but let's keep watch.

Penny stocks are for suckers, and six other rules for better investing -- and tuning out the tweet noise.

Short-term traders may want to nail down profits and be careful in their trading strategy with this name.

Isaac Newton's first lesson: An object in motion stays in motion with the same speed and in the same direction unless acted upon by an unbalanced force.

Mark Zuckerberg's AI team unveiled big plans for AI in an email chain

These 10 compact and midsized sport utility vehicles earned CR’s highest marks, and they sell for wallet-friendly prices.

Here’s what could be next in the AI boom.